Concomitant Treatment of Permanent Atrial Fibrillation

PHASE3CompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2007

Study Completion Date

November 30, 2010

Conditions
Atrial Fibrillation
Interventions
DEVICE

Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System

Surgical bipolar radiofrequency ablation using the AtriCure Bipolar System

Trial Locations (10)

23507

Sentara Norfolk Hospital, Norfolk

44195

Cleveland Clinic, Cleveland

46290

Heart Center of Indiana, Indianapolis

48109

University of Michigan, Ann Arbor

49506

Spectrum Health, Grand Rapids

53715

St. Mary's Hospital Medical Center, Madison

55902

Mayo Clinic, Rochester

63110

Washington University, St Louis

77030

The Methodist Hospital, Houston

99220

Sacred Heart Medical Center, Seattle

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AtriCure, Inc.

INDUSTRY

NCT00566787 - Concomitant Treatment of Permanent Atrial Fibrillation | Biotech Hunter | Biotech Hunter